Recall Z-2208-2019— Abbott Ireland Diagnostics Division

Class II · Terminated

Class II FDA medical device recall by Abbott Ireland Diagnostics Division, initiated 2018-11-21, terminated 2021-03-25. It names one FDA 510(k) clearance: K983759. Product: Alinity i Ferritin Reagent Kit, List Number 07P6530 The Alinity i Ferritin assay is a chemiluminescent microparticle immunoassay (CMIA) used for the quantitative determination of ferritin in human serum and plasma on the Alinity i analyzer.. Reason: Abbott has become aware of a manufacturing issue that can result in damage to a bottle neck in some of the reagent cartridges found in the lots listed in Appendix A. If a bottle neck is damaged, it may cause a failure during the reagent loading process on the Alinity i instrument..

Recalling firm
Abbott Ireland Diagnostics Division
Classification
Class II
Status
Terminated
Initiated
2018-11-21
Terminated
2021-03-25
Firm location
Co. Longford, N/A, Ireland

510(k) clearances named in this recall

1 on FDA's record

K-numbers as listed on FDA's Recall Enterprise System record for this event (openFDA device/recall k_numbers). The recall may also cover devices cleared under other submissions not named here.

Product description

Alinity i Ferritin Reagent Kit, List Number 07P6530 The Alinity i Ferritin assay is a chemiluminescent microparticle immunoassay (CMIA) used for the quantitative determination of ferritin in human serum and plasma on the Alinity i analyzer.

Reason for recall

Abbott has become aware of a manufacturing issue that can result in damage to a bottle neck in some of the reagent cartridges found in the lots listed in Appendix A. If a bottle neck is damaged, it may cause a failure during the reagent loading process on the Alinity i instrument.

Data sourced from openFDA. This site is unofficial and independent of the FDA.